STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
174
13F, latest reported quarter
Conversions, 180 days
15
Codes C/M, not in net · $449.8K priced
What the filings say about CWK
Insiders, 180 days
-$853.6K net sold
2 sellers · 0% of sales under a 10b5-1 plan
Planned sales (Form 144), 90 days
$389.5K
2 notices
Cushman & Wakefield insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, Cushman & Wakefield Ltd. insiders sold a net $853.6K of stock across 33 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-28.
8 earlier Form 4 trades (code P or S) here by this insider (8 sales), the last on Jun 4, 2026.
The trade is 21.4% of the 58,376 shares held after it.
1 other insider sold within 30 days.
174 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: See Remarks Robinson Nathaniel sold about $167.4K of CWK on Sep 8, 2026; 1 other insider sold within 30 days and 174 funds added in the latest 13F quarter.
First Form 4 purchase or sale (code P or S) here by this insider on our record.
The trade is 293.0% of the 5,461 shares held after it.
1 other insider sold within 30 days.
174 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: See Remarks Sayed Laurida sold about $222.1K of CWK on Aug 13, 2026; 1 other insider sold within 30 days and 174 funds added in the latest 13F quarter.
7 earlier Form 4 trades (code P or S) here by this insider (7 sales), the last on May 12, 2026.
The trade is 35.0% of the 70,876 shares held after it.
No other insider sold within 30 days.
174 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: See Remarks Robinson Nathaniel sold about $329.0K of CWK on Jun 4, 2026, the largest insider sale at the company since 2024; 174 funds added in the latest 13F quarter.
6 earlier Form 4 trades (code P or S) here by this insider (6 sales), the last on Mar 3, 2026.
The trade is 10.4% of the 95,704 shares held after it.
No other insider sold within 30 days.
174 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: See Remarks Robinson Nathaniel sold about $135.2K of CWK on May 12, 2026, the largest insider sale at the company since 2024; 174 funds added in the latest 13F quarter.
5 earlier Form 4 trades (code P or S) here by this insider (5 sales), the last on Feb 29, 2024.
The trade is 9.5% of the 105,704 shares held after it.
No other insider sold within 30 days.
174 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: See Remarks Robinson Nathaniel sold about $135.0K of CWK on Mar 3, 2026, the largest insider sale at the company since 2024; 174 funds added in the latest 13F quarter.
33 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Nobody has filed for crossing 5%. That is a fact, not missing data.
CWK planned insider sales (Form 144)
Notice of intent to sell, filed before any sale
Robinson Nathaniel
Filed 2026-09-08
$167.4K
Sayed Laurida
Filed 2026-08-13
$222.1K
CWK mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
CHANNING INTRINSIC VALUE SMALL-CAP FUND
$217.1K position · as of 2026-07-31
2.1%
Victory Integrity Small-Cap Value Fund
$12.3M position · as of 2026-06-30
1.1%
Invesco S&P SmallCap Value with Momentum ETF
$7.2M position · as of 2026-07-31
1.1%
Victory Integrity Small/Mid-Cap Value Fund
$3.9M position · as of 2026-06-30
1.0%
NAA SMALL CAP VALUE SERIES
$445.9K position · as of 2026-06-30
0.9%
SmallCap Value Fund II
$10.4M position · as of 2026-07-31
0.8%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Executive pay vs shareholder return · Ms.MacKay
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2025
$9.5M
$15.6M
$3.5M
+9%
+116%
2024
$9.7M
$12.6M
$4.9M
-12%
+74%
2022
$8.6M
$1.8M
$5.9M
-16%
+10%
2021
$20.0M
$31.0M
$4.6M
+50%
+77%
2020
$9.1M
$470.0K
$2.4M
-27%
-1%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $853.6K sold by insiders over 180 days, 174 funds added last quarter, $389.5K in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$10.8B
four quarters, 2025-07-01 to 2026-06-30
Revenue, TTM CWK
FY Dec 2025
$10.3B
FY Dec 2024
$9.4B
FY Dec 2023
$9.5B
FY Dec 2022
$10.1B
FY Dec 2021
$9.4B
Jun 2026
$2.8B
Mar 2026
$2.5B
Dec 2025
$2.9B
Sep 2025
$2.6B
Jun 2025
$2.5B
Mar 2025
$2.3B
Dec 2024
$2.6B
Sep 2024
$2.3B
At each fiscal year end
Single quarter
Net margin, TTM
+0.6%
net income over revenue, 2025-07-01 to 2026-06-30
Net margin, TTM CWK
FY Dec 2025
+0.9%
FY Dec 2024
+1.4%
FY Dec 2023
-0.4%
FY Dec 2022
+1.9%
FY Dec 2021
+2.7%
Jun 2026
+1.9%
Mar 2026
-0.5%
Dec 2025
-0.8%
Sep 2025
+2.0%
Jun 2025
+2.3%
Mar 2025
+0.1%
Dec 2024
+4.3%
Sep 2024
+1.4%
At each fiscal year end
Single quarter
Free cash flow, TTM
$249.1M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Free cash flow, TTM CWK
FY Dec 2025
$293.0M
FY Dec 2024
$167.0M
FY Dec 2023
$101.2M
FY Dec 2022
-$1.6M
FY Dec 2021
$495.7M
Jun 2026
$45.5M
Mar 2026
-$255.7M
Dec 2025
$234.3M
Sep 2025
$225.0M
Jun 2025
$300.0K
Mar 2025
-$166.6M
Dec 2024
$105.9M
Sep 2024
$186.7M
At each fiscal year end
Single quarter
Debt to equity
1.31x
long-term 2026-06-30 plus current 2026-06-30; equity 2026-06-30
Debt to equity CWK
FY Dec 2025
1.41x
FY Dec 2024
1.73x
FY Dec 2023
1.94x
FY Dec 2022
1.96x
FY Dec 2021
2.25x
Jun 2026
1.31x
Mar 2026
1.41x
Dec 2025
1.41x
Sep 2025
1.46x
Jun 2025
1.57x
Mar 2025
1.70x
Dec 2024
1.73x
Sep 2024
1.82x
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
0.11x
TTM operating cash flow over long-term 2026-06-30 plus current 2026-06-30
Cash flow to debt CWK
FY Dec 2025
0.12x
FY Dec 2024
0.07x
FY Dec 2023
0.05x
FY Dec 2022
0.02x
FY Dec 2021
0.17x
Jun 2026
0.11x
Mar 2026
0.09x
Dec 2025
0.12x
Sep 2025
0.07x
Jun 2025
0.05x
Mar 2025
0.06x
Dec 2024
0.07x
Sep 2024
0.10x
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+3.5%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity CWK
FY Dec 2025
+4.8%
FY Dec 2024
+7.7%
FY Dec 2023
-2.1%
FY Dec 2022
+12.6%
FY Dec 2021
+19.7%
Jun 2026
+3.5%
Mar 2026
+4.0%
Dec 2025
+4.8%
Sep 2025
+12.2%
Jun 2025
+11.6%
Mar 2025
+9.5%
Dec 2024
+7.7%
Sep 2024
+5.4%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+0.9%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets CWK
FY Dec 2025
+1.2%
FY Dec 2024
+1.7%
FY Dec 2023
-0.5%
FY Dec 2022
+2.5%
FY Dec 2021
+3.3%
Jun 2026
+0.9%
Mar 2026
+1.0%
Dec 2025
+1.2%
Sep 2025
+2.9%
Jun 2025
+2.8%
Mar 2025
+2.2%
Dec 2024
+1.7%
Sep 2024
+1.2%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
+8.5%
operating income after a 27.7% effective tax rate, over long-term 2026-06-30 plus current 2026-06-30 plus average of 2025-06-30 and 2026-06-30 minus cash
Return on invested capital CWK
FY Dec 2025
+9.2%
FY Dec 2024
+6.4%
FY Dec 2023
n/a
FY Dec 2022
+7.6%
FY Dec 2021
+10.1%
Jun 2026
+8.5%
Mar 2026
+9.0%
Dec 2025
+9.2%
Sep 2025
+9.8%
Jun 2025
+7.7%
Mar 2025
+6.9%
Dec 2024
+6.4%
Sep 2024
+5.3%
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
+9.2%
operating income (EBIT proxy) over average of 2025-06-30 and 2026-06-30 minus current liabilities
Return on capital employed CWK
FY Dec 2025
+8.8%
FY Dec 2024
+6.4%
FY Dec 2023
+3.8%
FY Dec 2022
+9.7%
FY Dec 2021
+9.3%
Jun 2026
+9.2%
Mar 2026
+8.9%
Dec 2025
+8.8%
Sep 2025
+8.6%
Jun 2025
+8.0%
Mar 2025
+6.9%
Dec 2024
+6.4%
Sep 2024
+5.1%
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
39.67x
close 2026-10-26 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
P/E, trailing CWK
FY Dec 2025
41.51x
FY Dec 2024
23.78x
FY Dec 2023
n/a
FY Dec 2022
14.32x
FY Dec 2021
20.40x
Jun 2026
44.63x
Mar 2026
37.15x
Dec 2025
41.51x
Sep 2025
16.58x
Jun 2025
12.58x
Mar 2025
14.81x
Dec 2024
23.78x
Sep 2024
36.84x
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$5.0B
market value at close 2026-10-26 on 2026-07-30 shares, plus long-term 2026-06-30 plus current 2026-06-30, minus cash 2026-06-30
Enterprise value CWK
FY Dec 2025
$5.7B
FY Dec 2024
$5.3B
FY Dec 2023
$4.9B
FY Dec 2022
$5.4B
FY Dec 2021
$7.5B
Jun 2026
$5.3B
Mar 2026
$5.0B
Dec 2025
$5.7B
Sep 2025
$5.9B
Jun 2025
$4.9B
Mar 2025
$4.7B
Dec 2024
$5.3B
Sep 2024
$5.4B
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+8.9%
TTM free cash flow over market value at close 2026-10-26
FCF yield CWK
FY Dec 2025
+7.8%
FY Dec 2024
+5.6%
FY Dec 2023
+4.1%
FY Dec 2022
-0.1%
FY Dec 2021
+10.0%
Jun 2026
+7.9%
Mar 2026
+7.2%
Dec 2025
+7.8%
Sep 2025
+4.5%
Jun 2025
+4.9%
Mar 2025
+5.8%
Dec 2024
+5.6%
Sep 2024
+7.9%
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
trailing EPS growth -66%, PEG needs growth
PEG, trailing CWK
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
0.10x
Jun 2025
0.01x
Mar 2025
0.01x
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
CWK ranks highest on growth (67th percentile) and institutional and government (66th), and lowest on insider conviction (13th), among Real Estate peers.
Profitability
63
Inputs
Return on equity+3.5% · 50 pct, sector of 230
Return on assets+0.9% · 48 pct, sector of 255
Return on invested capital+8.5% · 69 pct, sector of 49
Return on capital employed+9.2% · 85 pct, sector of 47
Financial health
45
Inputs
Debt to equity1.31x · 38 pct, sector of 210
Cash flow to debt0.11x · 53 pct, sector of 215
Growth
67
Inputs
Revenue growth, YoY+8.9% · 67 pct, sector of 244
Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Insider conviction
13
Inputs
Net Form 4 buying (codes P and S), 180d-$854K · 26 pct, sector of 156
Insider buyers, 180d0 · 0 pct, sector of 158
Institutional and government
66
Inputs
Funds adding, latest quarter174 · 66 pct, sector of 171
Congress net buyers, 365dno Congress trades in 365 days
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
19
Inputs
Short interest, % of float+6.5% · 33 pct, sector of 256
Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
EPA cases per $1B revenue, 5ynot measured for this sector, almost no peer has an event
New text in Risk Factors, latest 10-K+35.7% · 5 pct, sector of 212
1 not measured: US patents
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
6 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
CWK filings, in plain words
Are Cushman & Wakefield insiders buying or selling CWK?
In the 180 days to 2026-10-28, Cushman & Wakefield insiders were net sellers, a net $853.6K across purchases and sales reported on Form 4, by 2 sellers.
Are there planned insider sales of CWK?
Yes. 2 Form 144 notices of planned insider sales were filed in the 90 days to 2026-10-28, covering $389.5K of stock; the latest, by Robinson Nathaniel, was filed 2026-09-08.
Read the full summary
In the 180 days to 2026-10-28, Cushman & Wakefield insiders were net sellers of CWK, a net $853.6K across purchases and sales reported on Form 4 by 2 sellers. None of the 4 insider sales was flagged as made under a Rule 10b5-1 plan. Insiders filed 2 Form 144 notices of intent to sell in the 90 days to 2026-10-28, covering $389.5K of stock. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.